Scholarlink

<p>Atopic dermatitis (AD) is a chronic inflammatory skin condition characterized by pruritus and skin lesions. These symptoms can have a negative impact on quality of life (QOL) and mental health. This Adis Summary of Research reports the effects of lebrikizumab on QOL and patient-reported symptoms of anxiety and depression in adults and adolescents with moderate to severe AD.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Adis summary of research: Lebrikizumab improves quality of life and patient-reported symptoms of anxiety and depression in patients with moderate-to-severe atopic dermatitis

  • 期刊论文

  • 发表日期：

    2025年2月11日

查看全文
  • Hannah A. Blair

摘要

Atopic dermatitis (AD) is a chronic inflammatory skin condition characterized by pruritus and skin lesions. These symptoms can have a negative impact on quality of life (QOL) and mental health. This Adis Summary of Research reports the effects of lebrikizumab on QOL and patient-reported symptoms of anxiety and depression in adults and adolescents with moderate to severe AD.